Shinva Medical InstrumentLtd マネジメント

マネジメント基準チェック /34

Shinva Medical InstrumentLtdの CEO はBaoxian Gongで、 Feb2022年に任命され、の在任期間は 2.75年です。は、会社の株式の0.009%を直接所有しており、その価値はCN¥ 914.02K 。経営陣と取締役会の平均在任期間はそれぞれ3年と3.8年です。

主要情報

Baoxian Gong

最高経営責任者

CN¥2.3m

報酬総額

CEO給与比率	n/a
CEO在任期間	2.8yrs
CEOの所有権	0.009%
経営陣の平均在職期間	3yrs
取締役会の平均在任期間	3.8yrs

経営陣の近況

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

CEO（最高経営責任者

Baoxian Gong (48 yo)

2.8yrs

在職期間

CN¥2,312,900

報酬

Mr. Baoxian Gong is General Manager of Shinva Medical Instrument Co., Ltd., since February 23, 2022.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Baoxian Gong	General Manager	2.8yrs	CN¥2.31m	0.0086% CN¥ 914.0k
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.020% CN¥ 2.2m
Cai Xiang Li	Deputy GM & Secretary of the Board	7.3yrs	CN¥978.80k	0.036% CN¥ 3.8m
Jing Qu	Deputy General Manager	4.6yrs	CN¥1.57m	0.022% CN¥ 2.3m
Jiaqiang Wang	Deputy General Manager	2.3yrs	CN¥1.23m	0.0096% CN¥ 1.0m
Qingguo Zhu	Deputy General Manager	2.3yrs	CN¥1.64m	0.011% CN¥ 1.1m

3.0yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: 600587の経営陣は経験豊富であると考えられます ( 3年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.020% CN¥ 2.2m
Ailing Pan	Independent Director	4.3yrs	CN¥80.00k	データなし
Yu Quan Wang	Chairman	4.5yrs	CN¥1.25m	0.035% CN¥ 3.8m
Weijun Gu	Independent Director	4.4yrs	CN¥80.00k	0.0011% CN¥ 114.1k
Hongtao Cui	Employee Representative Director	7.6yrs	CN¥2.60m	0.023% CN¥ 2.5m
Xiao Li Zhao	Director	7.6yrs	CN¥1.03m	データなし
Yueyong Wang	Director	3.8yrs	CN¥33.30k	データなし
Xiao Li Li	Director	3.8yrs	CN¥94.00k	データなし
Li Yong Jiang	Independent Director	3.8yrs	CN¥80.00k	データなし
Lehai Mou	Chairman of the Supervisory Board	3.8yrs	データなし	データなし
Yuan Li	Independent Director	3.3yrs	CN¥80.00k	データなし
Fuquan Zhang	Director	1.3yrs	CN¥33.30k	データなし

3.8yrs

平均在職期間

56.5yo

平均年齢

経験豊富なボード: 600587の取締役会は経験豊富であると考えられます ( 3.8年の平均在任期間)。

Shinva Medical InstrumentLtd マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34